22nd Century Group News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.05.18	Public Health Leaders Urge FDA to Issue Final Rule for Reducing Nicotine in Cigarettes by March 2019 (Businesswire)
03.05.18	22nd Century Files 2018 First Quarter Report (Businesswire)
25.04.18	22nd Century Committed to Advancing FDA’s Nicotine Mandate (Businesswire)
23.04.18	Food and Drug Law Institute Publishes Public Policy Article by 22nd Century’s Dr. James Swauger (Businesswire)
19.03.18	FDA Publishes Advance Notice of Proposed Rulemaking (ANPRM) on Lowering Nicotine in Cigarettes (Businesswire)
06.03.18	17th World Conference on Tobacco or Health Will Feature Discussion on the FDA’s Plan to Dramatically Reduce Nicotine in Cigarettes (Businesswire)
22.02.18	22nd Century Group to Present International Survey Findings at the Society for Research on Nicotine and Tobacco Annual Meeting (Businesswire)
01.02.18	22nd Century to Present at BIO CEO & Investor Conference (Businesswire)
04.12.17	22nd Century Hires Former BAT Head of Plant Biotechnology (Businesswire)
30.11.17	22nd Century Ships 2.4 Million SPECTRUM® Cigarettes for the National Institute on Drug Abuse (Businesswire)
22.11.17	Anticipating FDA’s "Reduced Nicotine Mandate,” 22nd Century Will Discontinue U.S. Sales of RED SUN Brand (Businesswire)
09.11.17	22nd Century Group Files 2017 Third Quarter Report and Announces Conference Call to Provide Business Update (Businesswire)
02.11.17	22nd Century Hires Former Reynolds American Vice President (Businesswire)
06.10.17	Phase III Study using 22nd Century’s SPECTRUM® Research Cigarettes Demonstrates Immediate Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm (Businesswire)
25.09.17	22nd Century von restriktivem Lizenzvertrag mit British American Tobacco befreit (Businesswire)
19.09.17	Global Legal Cannabis Sales Projected to Grow (PR Newswire)
13.09.17	Cannabis Industry Becoming one of the Fastest Growing Sectors With Infusion of Innovative Services and Technology Advancements (PR Newswire)
13.09.17	Cannabis Industry Becoming one of the Fastest Growing Sectors With Infusion of Innovative Services and Technology Advancements (PR Newswire)
16.08.17	FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators (PR Newswire)
16.08.17	FDA Proposal Puts Spotlight on Big Tobacco and Industry Innovators (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
10.08.17	Biotech Influence on Cannabinoid-based Drug Development Leading to Latest Clinical Trials for Treatments for Chronic Disorders (PR Newswire)
08.08.17	Legal Cannabis and CBD Based Products Continue to Show Robust Growth (PR Newswire)
08.08.17	Legal Cannabis and CBD Based Products Continue to Show Robust Growth (PR Newswire)
26.07.17	How These Biotech Stocks are Performing? -- Intrexon, 22nd Century, Corcept Therapeutics, and Achaogen (PR Newswire)
20.07.17	The Next Gold Rush is Green (PR Newswire)
18.07.17	Where the Smart Money is Looking This Summer (PR Newswire)
22.06.17	Pharmaceutical Advancements in Medicinal Marijuana Continue to Evolve While Producing Higher Quality Cannabinoid Extracts (PR Newswire)
22.06.17	Pharmaceutical Advancements in Medicinal Marijuana Continue to Evolve While Producing Higher Quality Cannabinoid Extracts (PR Newswire)
15.06.17	New International Survey Shows Overwhelming Support for Very Low Nicotine Cigarettes (Businesswire)
13.06.17	Legal Cannabis Sales Grow in North America (PR Newswire)
07.06.17	Cannabis Grow Operations and Development of Newest Products Boosting Growth in Hydroponic Supplies Market (PR Newswire)
07.06.17	Cannabis Grow Operations and Development of Newest Products Boosting Growth in Hydroponic Supplies Market (PR Newswire)
06.06.17	Premium Cannabidiol Products Showing Robust Growth Momentum in Legal Marijuana Sector (PR Newswire)
06.06.17	Premium Cannabidiol Products Showing Robust Growth Momentum in Legal Marijuana Sector (PR Newswire)
05.06.17	Biotech Stock Performance Review -- 22nd Century, Calithera Biosciences, Five Prime Therapeutics, and Advaxis (PR Newswire)
11.05.17	Biotech Infusion Into Cannabis Product Development is Creating Strong Industry Growth Combination (PR Newswire)
11.05.17	Biotech Infusion Into Cannabis Product Development is Creating Strong Industry Growth Combination (PR Newswire)
04.04.17	Drug Screening Industry to Grow on Heels of Rising THC, Opioid and Other Recreational Drug Use (PR Newswire)
04.04.17	Drug Screening Industry to Grow on Heels of Rising THC, Opioid and Other Recreational Drug Use (PR Newswire)
03.04.17	Research Reports Initiation on Biotech Stocks -- Alcobra, Cerus, 22nd Century, and Moleculin Biotech (PR Newswire)
28.03.17	The Growth of Legal Cannabis in Approved States (PR Newswire)
22.03.17	Recent Data Projects Growth in the Legal Cannabis Market (PR Newswire)
17.03.17	The Data Surrounding the Legal Cannabis Markets (PR Newswire)
15.03.17	Cannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising Demand (PR Newswire)
15.03.17	Cannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising Demand (PR Newswire)
09.02.17	Technical Reports on Biotech Stocks -- Progenics Pharma, Intrexon, Synthetics Biologics, and 22nd Century (PR Newswire)
12.01.17	Cannabis Stocks Positioning to Regain Momentum in 2017 (PR Newswire)
21.12.16	How These Biotech Stocks are Faring? -- Inovio Pharma, 22nd Century, Omeros, and Cerulean Pharma (PR Newswire)
06.12.16	Rising Global Demand for Cannabis Products and Grow Equipment Continues to Drive Legal Marijuana Opportunity (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	74.20	0.13 %	K V
Swiss Life Hldg	689.40	0.06 %	K V
Kuehne+Nagel Int	202.30	0.00 %	K V
Swisscom	501.50	-0.30 %	K V
Swiss Re	129.10	-0.39 %	K V
Logitech Intl	73.02	-2.41 %	K V
Roche Hldg G	246.70	-3.25 %	K V
UBS Group	26.89	-3.34 %	K V
Part Grp Hldg	1’217.00	-4.29 %	K V
ABB	48.73	-5.42 %	K V

Nachrichten zu 22nd Century Group Inc

Aktien Top/Flop

Meistgelesene Nachrichten